118 related articles for article (PubMed ID: 24811211)
1. The biocompatibility evaluation of mPEG-PLGA-PLL copolymer and different LA/GA ratio effects for biocompatibility.
He Z; Wang Q; Sun Y; Shen M; Zhu M; Gu M; Wang Y; Duan Y
J Biomater Sci Polym Ed; 2014; 25(9):943-64. PubMed ID: 24811211
[TBL] [Abstract][Full Text] [Related]
2. Degradation behavior and biosafety studies of the mPEG-PLGA-PLL copolymer.
He Z; Sun Y; Cao J; Duan Y
Phys Chem Chem Phys; 2016 Apr; 18(17):11986-99. PubMed ID: 27067001
[TBL] [Abstract][Full Text] [Related]
3. Biocompatibility Assessment of Polyethylene Glycol-Poly L-Lysine-Poly Lactic-Co-Glycolic Acid Nanoparticles In Vitro and In Vivo.
Guo L; Chen B; Liu R; Xia G; Wang Y; Li X; Wei C; Wang X; Jiang H
J Nanosci Nanotechnol; 2015 May; 15(5):3710-9. PubMed ID: 26504996
[TBL] [Abstract][Full Text] [Related]
4. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
[TBL] [Abstract][Full Text] [Related]
5. Intracellular trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomas.
Liu P; Sun Y; Wang Q; Sun Y; Li H; Duan Y
Biomaterials; 2014 Jan; 35(2):760-70. PubMed ID: 24148242
[TBL] [Abstract][Full Text] [Related]
6. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
Liu P; Yu H; Sun Y; Zhu M; Duan Y
Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
[TBL] [Abstract][Full Text] [Related]
7. Biocompatibility of filomicelles prepared from poly(ethylene glycol)-polylactide diblock copolymers as potential drug carrier.
Shen X; Liu X; Li R; Yun P; Li C; Su F; Li S
J Biomater Sci Polym Ed; 2017 Oct; 28(15):1677-1694. PubMed ID: 28627288
[TBL] [Abstract][Full Text] [Related]
8. PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma.
Cai C; Xie Y; Wu L; Chen X; Liu H; Zhou Y; Zou H; Liu D; Zhao Y; Kong X; Liu P
Sci Rep; 2017 Apr; 7():46250. PubMed ID: 28387375
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of blood compatibility of surface modification treated poly (D, L-lactic and glycolic acid) with mPEG block copolymer].
Nie Y; Duan Y; Zhang Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Apr; 24(2):336-9. PubMed ID: 17591255
[TBL] [Abstract][Full Text] [Related]
10. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.
Guan Q; Sun S; Li X; Lv S; Xu T; Sun J; Feng W; Zhang L; Li Y
J Mater Sci Mater Med; 2016 Feb; 27(2):24. PubMed ID: 26704541
[TBL] [Abstract][Full Text] [Related]
11. cRGD conjugated mPEG-PLGA-PLL nanoparticles for SGC-7901 gastric cancer cells-targeted Delivery of fluorouracil.
Liu P; Wang H; Wang Q; Sun Y; Shen M; Zhu M; Wan Z; Duan Y
J Nanosci Nanotechnol; 2012 Jun; 12(6):4467-71. PubMed ID: 22905486
[TBL] [Abstract][Full Text] [Related]
12. Poly(ester anhydride)/mPEG amphiphilic block co-polymer nanoparticles as delivery devices for paclitaxel.
Liang Y; Xiao L; Li Y; Zhai Y; Xie C; Deng L; Dong A
J Biomater Sci Polym Ed; 2011; 22(4-6):701-15. PubMed ID: 20566053
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of the genotoxicity of a family of novel MeO-PEG-poly(D,L-lactic-co-glycolic acid)-PEG-OMe triblock copolymer and PLGA nanoparticles.
He L; Yang L; Zhang ZR; Gong T; Deng L; Gu Z; Sun X
Nanotechnology; 2009 Nov; 20(45):455102. PubMed ID: 19822931
[TBL] [Abstract][Full Text] [Related]
15. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
[TBL] [Abstract][Full Text] [Related]
16. Enhanced delivery of PEAL nanoparticles with ultrasound targeted microbubble destruction mediated siRNA transfection in human MCF-7/S and MCF-7/ADR cells in vitro.
Teng Y; Bai M; Sun Y; Wang Q; Li F; Xing J; Du L; Gong T; Duan Y
Int J Nanomedicine; 2015; 10():5447-57. PubMed ID: 26346350
[TBL] [Abstract][Full Text] [Related]
17. Investigation of PEG-PLGA-PEG nanoparticles-based multipolyplexes for IL-18 gene delivery.
Nie Y; Zhang ZR; He B; Gu Z
J Biomater Appl; 2012 May; 26(8):893-916. PubMed ID: 21273262
[TBL] [Abstract][Full Text] [Related]
18. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
[TBL] [Abstract][Full Text] [Related]
19. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate.
Kim SH; Jeong JH; Chun KW; Park TG
Langmuir; 2005 Sep; 21(19):8852-7. PubMed ID: 16142970
[TBL] [Abstract][Full Text] [Related]
20. cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer.
Liu P; Qin L; Wang Q; Sun Y; Zhu M; Shen M; Duan Y
Biomaterials; 2012 Oct; 33(28):6739-47. PubMed ID: 22763223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]